01 12care4
02 4Amphastar Pharmaceuticals
03 1Biological E
04 2Eli Lilly
05 5Novo Nordisk
06 1ORIFARM GROUP AS
07 5Xeris Pharmaceuticals
01 2Glucagon 1Mg 1 Unit Parenteral Use
02 1INJ
03 2INJECTABLE;INJECTION
04 3Nasal powder
05 1POWDER
06 1POWDER;NASAL
07 2Powder and liquid to the injection fluid, resolution
08 1Pulver
09 5SOLUTION;SUBCUTANEOUS
10 1Vial
01 2DISCN
02 1Ethical
03 1Originator
04 6RX
05 9Blank
01 2BAQSIMI
02 4Baqsimi
03 2GLUCAGON
04 2GVOKE HYPOPEN
05 1GVOKE KIT
06 2GVOKE PFS
07 2Glucagen
08 1Glucagen Hypo
09 2Glucagon Novo Nordisk
10 1Blank
01 1Canada
02 1India
03 2Italy
04 5Norway
05 1South Africa
06 1Switzerland
07 8USA
Regulatory Info :
Registration Country : Norway
Brand Name : Baqsimi
Dosage Form : Nasal powder
Dosage Strength : mg
Packaging : Endo container 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL
Packaging :
Approval Date : 2020-12-28
Application Number : 208086
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BAQSIMI
Dosage Form : POWDER;NASAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2019-07-24
Application Number : 210134
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Baqsimi
Dosage Form : Nasal powder
Dosage Strength : mg
Packaging : Endo container 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Ethical
Registration Country : Canada
Brand Name : BAQSIMI
Dosage Form : POWDER
Dosage Strength : 3MG/CONTAINER
Packaging :
Approval Date :
Application Number : 2492415
Regulatory Info : Ethical
Registration Country : Canada
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Vial
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-09-11
Application Number : 20928
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Switzerland
Brand Name : Baqsimi
Dosage Form : Pulver
Dosage Strength : 3mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : Glucagen Hypo
Dosage Form : Glucagon 1Mg 1 Unit Parenteral Use
Dosage Strength : 1 vial 1 mg + 1 syringe 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Glucagen
Dosage Form : Glucagon 1Mg 1 Unit Parenteral Use
Dosage Strength : 1 vial 1 mg + 1 ampoule solv 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Glucagon Novo Nordisk
Dosage Form : Powder and liquid to the injection fluid, resolution
Dosage Strength : 1 mg
Packaging : Set
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Glucagon Novo Nordisk
Dosage Form : Powder and liquid to the injection fluid, resolution
Dosage Strength : 1 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Glucagen
Dosage Form : INJ
Dosage Strength : 1mg
Packaging : 1X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Norway
Brand Name : Baqsimi
Dosage Form : Nasal powder
Dosage Strength : mg
Packaging : Endo container 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : DISCN
Registration Country : USA
Brand Name : GVOKE PFS
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML)
Packaging :
Approval Date : 2019-09-10
Application Number : 212097
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE PFS
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Packaging :
Approval Date : 2019-09-10
Application Number : 212097
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE HYPOPEN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML)
Packaging :
Approval Date : 2019-09-10
Application Number : 212097
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE HYPOPEN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Packaging :
Approval Date : 2019-09-10
Application Number : 212097
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GVOKE KIT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Packaging :
Approval Date : 2021-08-20
Application Number : 212097
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?
